Reconsidering the role of prophylactic pancreaticojejunostomy in pancreatic enucleation: balancing the benefits and risks
ANZ Journal of Surgery · 2024
DOI: 10.1111/ans.18775 ↗Kurz gefasst
Fachartikel in der Zeitschrift ANZ Journal of Surgery, 2024. Verfasst von Yihua Shi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China. Hauptthemen laut MEDLINE: Pancreaticojejunostomy, Pancreatic Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Clinical Research Project of Health Industry of Shanghai Municipal Health Commission, Excellence project of Shanghai Municipal Health Commission, Eyas Project of Shanghai Anticancer Association.
Abstract (Originalsprache)
Background
The incidence of postoperative pancreatic fistula (POPF) following enucleation is high, and prophylactic pancreaticojejunostomy (PPJ) is frequently performed. Minimally invasive enucleation (MEN) has been demonstrated to be safe and feasible, leaving most enucleation wounds exposed.
Methods
The clinical data of 40 patients who underwent open enucleation with PPJ at our center between 2012 and 2021 were compared with those of 80 patients who underwent MEN.
Results
The MEN group had better outcomes than the PPJ group in terms of intraoperative bleeding (50.0 versus 100.0 mL), postoperative semi‐liquid diet recovery (2.0 versus 5.0 days), and postoperative length of stay (7.7 versus 12.5 days). While the MEN group had higher rates of complex enucleation (60.0% versus 40.0%), main pancreatic duct repair (32.5% versus 10.0%), discharge with drains (48.8% versus 25.0%), and grade B POPFs (47.5% versus 17.5%). Both surgical methods effectively preserved pancreatic function; however, two patients in the PPJ group experienced severe haemorrhaging and died. Additionally, during the follow‐up period, gastrointestinal bleeding was found and discomfort in the surgical area was reported.
Conclusion
Pancreatic enucleation combined with PPJ should be avoided, and although a biochemical or grade B POPF may develop after MEN, it can be compensated for by preserving pancreatic function and ensuring a good long‐term quality of life in the patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
- Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
- Shanghai Pancreatic Cancer Institute, Shanghai, China.
- Pancreatic Cancer Institute, Fudan University, Shanghai, China.
ORCID-Profile: Xiaowu Xu
Förderung
- Clinical Research Project of Health Industry of Shanghai Municipal Health Commission
- Excellence project of Shanghai Municipal Health Commission
- Eyas Project of Shanghai Anticancer Association
- Sailing Project of Science and Technology Commission of Shanghai Municipality
Zitieren
APA
Shi, Y., Li, Z., Li, B., Chen, H., Chen, C., Ji, S., Yu, X., & Xu, X. (2024). Reconsidering the role of prophylactic pancreaticojejunostomy in pancreatic enucleation: balancing the benefits and risks. ANZ Journal of Surgery. https://doi.org/10.1111/ans.18775
Vancouver
Shi Y, Li Z, Li B, Chen H, Chen C, Ji S, et al. Reconsidering the role of prophylactic pancreaticojejunostomy in pancreatic enucleation: balancing the benefits and risks. ANZ Journal of Surgery. 2024. doi:10.1111/ans.18775
BibTeX
@article{Shi2024,
author = {Shi, Yihua and Li, Zheng and Li, Borui and Chen, Haidi and Chen, Chen and Ji, Shunrong and Yu, Xianjun and Xu, Xiaowu},
title = {Reconsidering the role of prophylactic pancreaticojejunostomy in pancreatic enucleation: balancing the benefits and risks},
journal = {ANZ Journal of Surgery},
year = {2024},
doi = {10.1111/ans.18775}
}
EUVIMED